Search filters

List of works by Per Johansson

A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.

scientific article

Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders

scientific article published on 19 September 2016

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease

scientific article

Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population

scientific article published in January 2011

Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility

scientific article published on 13 May 2011

Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease

scientific article published on 7 October 2015

Cognitive medicine - a new approach in health care science

scientific article published on 8 February 2018

Converging pathways of chromogranin and amyloid metabolism in the brain

scientific article published on January 2010

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

scientific article

Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease

scientific article published on 26 August 2015

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease

scientific article published on May 2016

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease

scientific article

Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study

scientific article published on 22 December 2011

Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women

scholarly article by Per Johansson et al published 5 August 2011 in Clinical Endocrinology

Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease

scientific article published on 9 November 2015

Psychometric testing of a Swedish version of the Apathy Evaluation Scale.

scientific article published on 20 June 2017

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease

scientific article

Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment

scientific article

Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease

scientific article

Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease

scholarly article by Per Johansson et al published September 2013 in Psychoneuroendocrinology

The ELISA-measured increase in cerebrospinal fluid tau that discriminates Alzheimer's disease from other neurodegenerative disorders is not attributable to differential recognition of tau assembly forms

scientific article published in January 2013

The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk

scientific article published on 01 August 2019

The TECH@HOME study, a technological intervention to reduce caregiver burden for informal caregivers of people with dementia: study protocol for a randomized controlled trial

scientific article

The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease

scientific article